Eric Van Belle



  1. Vincent F, Rauch A, Spillemaeker H, Vincentelli A, Paris C, Rosa M, et al. Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory: The Seatbelt of Mini-Invasive Transcatheter Aortic Valve Replacement?. JACC Cardiovasc Interv. 2018;11:1775-1778 pubmed publisher
  2. Vincent F, Rauch A, Loobuyck V, Robin E, Nix C, Vincentelli A, et al. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support. J Am Coll Cardiol. 2018;71:2106-2118 pubmed publisher
    ..This modulation of VWF levels could explain the relationship between pulsatility and bleeding observed in CF-MCS recipients. Preservation of pulsatility may be a new target to improve clinical outcomes of patients. ..
  3. Collet J, Berti S, Cequier A, Van Belle E, Lefevre T, Leprince P, et al. Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial. Am Heart J. 2018;200:44-50 pubmed publisher
    ..ATLANTIS tests the superiority of an apixaban-based strategy versus the recommended standard of care strategy to reduce the risk of post-TAVR thromboembolic and bleeding complications in an all comer population. ..
  4. Van Belle E, Gil R, Klauss V, Balghith M, Meuwissen M, Clerc J, et al. Impact of Routine Invasive Physiology at Time of Angiography in Patients With Multivessel Coronary Artery Disease on Reclassification of Revascularization Strategy: Results From the DEFINE REAL Study. JACC Cardiovasc Interv. 2018;11:354-365 pubmed publisher
    ..9%) and investigation of more vessels is associated with higher reclassification rates. ..